Glyburide, a NLRP3 Inhibitor, Decreases Inflammatory Response and Is a Candidate to Reduce Pathology in Leishmania Braziliensis Infection

Journal of Investigative Dermatology - United Kingdom
doi 10.1016/j.jid.2019.05.025